These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 18602729

  • 1. Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.
    Zhu FC, Zhou W, Pan H, Lu L, Gerez L, Nauta J, Giezeman K, de Bruijn I.
    Vaccine; 2008 Aug 18; 26(35):4579-84. PubMed ID: 18602729
    [Abstract] [Full Text] [Related]

  • 2. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 18; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 3. Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity.
    Giezeman KM, Nauta J, de Bruijn IA, Palache AM.
    Vaccine; 2009 Apr 21; 27(18):2414-7. PubMed ID: 19368782
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia.
    Morales A, Arias Salazar J, Salazar Y, García A, Arnoux S, Arancibia A, Deroche C, Rey E.
    Medicina (B Aires); 2003 Apr 21; 63(3):197-204. PubMed ID: 12876902
    [Abstract] [Full Text] [Related]

  • 5. [Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly].
    Li RC, Fang HH, Li YP, Liu YP, Nong Y, Huang GB.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun 21; 29(6):548-51. PubMed ID: 19040034
    [Abstract] [Full Text] [Related]

  • 6. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.
    de Bruijn I, Meyer I, Gerez L, Nauta J, Giezeman K, Palache B.
    Vaccine; 2007 Dec 21; 26(1):119-27. PubMed ID: 18063446
    [Abstract] [Full Text] [Related]

  • 7. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J.
    Vaccine; 2009 Jun 02; 27(27):3561-7. PubMed ID: 19464535
    [Abstract] [Full Text] [Related]

  • 9. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
    Sindoni D, La Fauci V, Squeri R, Cannavò G, Bacilieri S, Panatto D, Gasparini R, Amicizia D.
    J Prev Med Hyg; 2009 Jun 02; 50(2):121-6. PubMed ID: 20099444
    [Abstract] [Full Text] [Related]

  • 10. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
    Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ.
    J Infect Dis; 2009 Sep 15; 200(6):849-57. PubMed ID: 19673652
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.
    Medicina (B Aires); 2007 Sep 15; 67(4):351-9. PubMed ID: 17891930
    [Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.
    Wu J, Liu SZ, Dong SS, Dong XP, Zhang WL, Lu M, Li CG, Zhou JC, Fang HH, Liu Y, Liu LY, Qiu YZ, Gao Q, Zhang XM, Chen JT, Zhong X, Yin WD, Feng ZJ.
    Vaccine; 2010 Aug 31; 28(38):6221-7. PubMed ID: 20638454
    [Abstract] [Full Text] [Related]

  • 13. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
    Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, Barben JL, Rarrick K, Stek JE, Chung MO, Schödel FP, Wang WW, Xu J, Chan IS, Silber JL, Schlienger K.
    J Am Geriatr Soc; 2007 Oct 31; 55(10):1499-507. PubMed ID: 17908055
    [Abstract] [Full Text] [Related]

  • 14. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
    Lina B, Fletcher MA, Valette M, Saliou P, Aymard M.
    Biologicals; 2000 Jun 31; 28(2):95-103. PubMed ID: 10885616
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age.
    Vesikari T, Block SL, Guerra F, Lattanzi M, Holmes S, Izu A, Gaitatzis N, Hilbert AK, Groth N.
    Pediatr Infect Dis J; 2012 May 31; 31(5):494-500. PubMed ID: 22301476
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and tolerability of a trivalent influenza subunit vaccine (Influvac) in high-risk children aged 6 months to 4 years.
    Daubeney P, Taylor CJ, McGaw J, Brown EM, Ghosal S, Keeton BR, Palache B, Kerstens R.
    Br J Clin Pract; 1997 Mar 31; 51(2):87-90. PubMed ID: 9158251
    [Abstract] [Full Text] [Related]

  • 17. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
    Baldo V, Baldovin T, Floreani A, Carraro AM, Trivello R, Family Medicine Group of Pianiga.
    Vaccine; 2007 May 16; 25(20):3955-61. PubMed ID: 17383057
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL.
    Pediatrics; 2007 Jun 16; 119(6):1076-82. PubMed ID: 17545373
    [Abstract] [Full Text] [Related]

  • 19. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730
    [Abstract] [Full Text] [Related]

  • 20. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P.
    Vaccine; 2009 Dec 09; 27(52):7304-12. PubMed ID: 19849996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.